The Importance of Early Diagnosis in Alzheimer’s: Understanding New Testing Advances & Why Timing Matters
Join Sarah Kremen, Neurologist at Cedars-Sinai, and Veronica Romo, Licensed Social Worker, for an informative discussion on the latest advancements in Alzheimer’s testing and diagnosis, why early awareness matters, and how a timely diagnosis empowers individuals and families to make proactive, informed decisions. We will also explore the critical role caregivers and loved ones play in recognizing early signs, advocating for evaluation, and providing meaningful support throughout the journey.
Early detection of Alzheimer’s disease is transforming the way individuals and families navigate a diagnosis. With emerging diagnostic tools and new testing methods offering greater clarity than ever before, understanding the benefits of identifying cognitive changes early can significantly impact care planning, treatment options, and overall quality of life.
Whether you are a family member, caregiver, or professional, this program will provide valuable insight into how early detection can create opportunities for planning, connection, and compassionate care.
For questions, please email Kate McGloon, Director of Community Partnerships, at KMcGloon@kensingtonsl.com.
- Sub-Headline With Experts at Cedars-Sinai
Change my RSVP
Speakers
-
Veronica Romo, LCSWLearn MoreVeronica Romo is a social worker at the Cedars-Sinai Memory Clinic, where she works closely with individuals and families navigating the challenges of memory loss and dementia. With more than 10 years of experience supporting people through difficult times, she is passionate about helping caregivers feel prepared and supported. Her own personal experience with dementia shapes the empathy and understanding she brings to both her clinic and private practice work.
-
Sarah Kremen, MD, NeurologistLearn MoreDr. Sarah Kremen is Associate Professor of Neurology and Director of the Behavioral Neurology Program and Behavioral Neurology and Neuropsychiatry Fellowship at the Jona Goldrich Center for Alzheimer’s and Memory Disorders at Cedars-Sinai Medical Center. She is also co-director of the Cedars-Sinai CurePSP Center of Care. Dr. Kremen treats patients with memory, language and other cognitive disorders due to Alzheimer’s and related neurodegenerative diseases (ADRD). She leads the Goldrich Center ADRD clinical trial program and has been a site PI for national and international ADRD interventional and observational studies ranging from healthy to asymptomatic disease to moderate dementia. She has expertise in study recruitment, cohort development, and peer and community education and outreach. Her clinical research interests include primary progressive aphasia and dementia with Lewy bodies, as well as patient research experience and barriers to clinical research participation.